Targeted Technology

Cardiovate is a medical technology company that targets transformational health care opportunities in tissue regeneration and repair.

neoSurgical is a start up Irish Medical Devices firm with a fresh perspective and an appetite for both technical innovation and intellectual challenge in the Surgical Devices industry.

Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing. Its device utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion. The company's products, VivAer for nasal airway obstruction and RhinAer for chronic rhinitis, leverage its proprietary temperature-controlled technology, which allows ENT physicians to improve patients’ symptoms with technologies that are appealing alternatives to invasive surgery.

Roxy’s Remedies provides natural grooming products for dogs with canine atopic dermatitis. Roxy’s Remedies' product line is formulated with sustainably cultivated, pharmaceutical-grade East Indian Sandalwood Oil (EISO) produced by TFS Corporation Ltd. EISO is a natural, calming ingredient that has been used as a traditional skin healing agent and is being developed by Santalis as a prescription drug for human skin conditions.

StemBioSys manufactures and develops novel, proprietary stem cell technologies to meet the promise of regenerative medicine in a surging global market. Housed in San Antonio, StemBioSys is led by an experienced management and scientific team.

Xenex is offering an effective approach to reducing the incidence of healthcare-associated infections. The Xenex mission is to save lives and reduce suffering by destroying deadly microorganisms that can cause hospital-acquired infections (HAIs). Xenex’s Pulsed Xenon Full Spectrum™ UV Disinfection Solution reduces the bacterial load often associated with an increased risk for HAIs. Since its commercial launch in June 2010, Xenex devices are now included in infection control protocols in almost three hundred hospitals throughout the U.S. Xenex was founded in 2009 and headquartered in San Antonio, Texas.

DNAtrix is a Texas-based company developing modified viruses for the treatment of the most aggressive forms of cancer. The company’s initial focus is on glioblastoma, a devastating brain tumor that is currently incurable. Since viruses are already good at killing cells, scientists have harnessed this ability by modifying a common cold virus so that it targets and kills cancer cells selectively. More than 35 patients have been treated with the cancer-killing virus, called DNX-2401, with excellent early results. Company’s lead product, DNX-2401, is the culmination of more than a decade of scientific and clinical research and is the most potent and effective oncolytic virus delivered to human brain tumors to date. DNAtrix is also working to expand its platform technology for treating other cancers, including brain metastases, ovarian and pancreatic cancer. Targeted cancer-killing viruses such as DNX-2401 represent an important new weapon in the fight against cancer.

Bluegrass Vascular Technologies is a medical technology company dedicated to developing and commercializing life-saving devices and methods that address shortcomings in vascular access procedures. Their first product, the Surfacer Inside-Out Access Catheter System is based on a foundation of success with over 400 Inside-Out procedures performed to-date in patients with the venous occlusive disease. The company was founded in 2011 and is headquartered in San Antonio, Texas.

Xenex is offering an effective approach to reducing the incidence of healthcare-associated infections. The Xenex mission is to save lives and reduce suffering by destroying deadly microorganisms that can cause hospital-acquired infections (HAIs). Xenex’s Pulsed Xenon Full Spectrum™ UV Disinfection Solution reduces the bacterial load often associated with an increased risk for HAIs. Since its commercial launch in June 2010, Xenex devices are now included in infection control protocols in almost three hundred hospitals throughout the U.S. Xenex was founded in 2009 and headquartered in San Antonio, Texas.

ViroXis is a bio-pharmaceutical company focused on developing and commercializing innovative, properietary, botanical pharmaceuticals derived from Sandalwood Oil. The hardwood oils of the East Indian and West Australian sandalwood trees, S.album and S. spicatum, have a long and extensive history of traditional use for a variety of conditions, including the successful treatment of various skin disorders, including skin viral and difficult-to-treat microbial infections.

BiO2 Medical offers Angel Catheter that provides prophylactic Pulmonary Embolism protection and access to the central venous system. It was formerly known as Artificial Airways. Bi02 Medical design, develops, and manufactures medical devices. It develops Angel Catheter, a catheter-based IVC filter for the prevention of pulmonary embolism in critical care patients worldwide. The Angel Catheter allows for insertion and access to the central venous system for administering medications, fluids, or blood products; blood sampling; and monitoring of central venous pressure. The company was founded in 2006 and is based in San Antonio, Texas with a research and development, and manufacturing facility in Golden, Colorado.

BiO2 Medical offers Angel Catheter that provides prophylactic Pulmonary Embolism protection and access to the central venous system. It was formerly known as Artificial Airways. Bi02 Medical design, develops, and manufactures medical devices. It develops Angel Catheter, a catheter-based IVC filter for the prevention of pulmonary embolism in critical care patients worldwide. The Angel Catheter allows for insertion and access to the central venous system for administering medications, fluids, or blood products; blood sampling; and monitoring of central venous pressure. The company was founded in 2006 and is based in San Antonio, Texas with a research and development, and manufacturing facility in Golden, Colorado.

Vidacare Corporation, a medical device company, engages in the development, manufacture, and marketing of intraosseous access devices for diagnostic, monitoring, and therapeutic applications. The company provides EZ-IO Product System, which is designed to provide controlled vascular access through the intraosseous route to patients in emergent situations when vascular access is challenging and impossible. It also offers EZ-IO power driver, which is designed to penetrate the intraosseous space by drilling through the bone with a hollow needle and integrated stylet that doubles as the forward cutting bit to secure its correct placement; and EZ-IO Vascular Access Pack, a kit developed for emergency medical specialists to provide access to IV and IO devices to gain vascular access. In addition, the company provides a suite of hematology/oncology products, including a power driver and needle sets for bone marrow aspiration and biopsy; and OnControl, a bone marrow system for clinicians to perform bone marrow aspiration and biopsy procedures. Its products are used in pre-hospital, emergency, crash cart, and rapid response applications, as well as in military and homeland security industries. Vidacare Corporation was founded in 2001 and is headquartered in San Antonio, Texas.